ICU Medical (ICUI) came out with quarterly earnings of $1.56 per share, beating the Zacks Consensus Estimate of $0.98 per share. This compares to earnings of $1.88 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 59.18%. A quarter ago, it was expected that this medical device maker would post earnings of $0.84 per share when it actually produced earnings of $0.96, delivering a surprise of 14.29%. Over the last four quarters, th ...

Core Points - ICU Medical, Inc. will release its second quarter 2024 earnings results on August 7, 2024, at approximately 4:00 p.m. ET [2] - A conference call to discuss the results will take place on the same day at 4:30 p.m. ET, accessible via phone and webcast [2] - ICU Medical is a leader in infusion systems and critical care products, focusing on quality and innovation for clinical customers worldwide [3]

ICU Medical (ICUI) came out with quarterly earnings of $0.96 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $1.74 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 14.29%. A quarter ago, it was expected that this medical device maker would post earnings of $1.18 per share when it actually produced earnings of $1.57, delivering a surprise of 33.05%.Over the last four quarters, the ...

ICU Medical, Inc Q1 2024 Conference Call Presentation May 7, 2024 > Any statement concerning Management's expectation with respect to future results is a forward-looking statement based upon the best information currently available to Management and assumptions Management believes are reasonable, but Management does not intend the statement to be a representation as to future results. > These forward-looking statements, including statements about continuing health crises, pandemics and epidemics, such as th ...

or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2024 (Former name, former address and former fiscal year, if changed since last report) For the transition period from: to Commission File No.: 001-34634 ICU MEDICAL, INC. (Exact name of registrant as spe ...

Exhibit 99.1 ICU Medical Announces First Quarter 2024 Results SAN CLEMENTE, Calif., May 7, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2024. Revenues by product line for the three months ended March 31, 2024 and 2023 were as follows (in millions): First Quarter 2024 Results First quarter 2024 revenue was $566.7 million, compared to $568.6 ...

SAN CLEMENTE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2024 earnings release and conference call. The Company will release its first quarter 2024 results on Tuesday, May 7th, 2024 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Tuesday, May 7th, 2024. ...

SAN CLEMENTE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2024 earnings release and conference call. The Company will release its first quarter 2024 results on Tuesday, May 7th, 2024 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Tuesday, May 7th, 2024. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-34634 ICU MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 33-0022692 (State or other jurisdiction of incorporation or ...

Exhibit 99.1 ICU Medical Announces Fourth Quarter 2023 Results and Provides Fiscal Year 2024 Guidance SAN CLEMENTE, Calif., February 27, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended December 31, 2023. Fourth Quarter 2023 Results Fourth quarter 2023 revenue was $587.9 million, compared to $578.0 million in the same period in the prior year. GAAP gross profit f ...